Showing results (181-190 of 266) with videos related to

Sort By:
Pageof 27
Cancer|May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyAlberto S Pappo, Gilles Vassal, John J Crowley, et al.
The Lancet. Oncology|December 2, 2019
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective studySheri L Spunt, Lynn Million, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer|May 26, 2025
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology GroupDaniel J Indelicato, Alexandra K Callan, Safia K Ahmed, et al.
JAMA Oncology|January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) StudyMarian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing SarcomaLillian M Guenther, Neekesh V Dharia, Linda Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Molecular Cancer Research : MCR|January 18, 2019
The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin TreatmentSamuel W Brady, Xiaotu Ma, Armita Bahrami, et al.
British Journal of Cancer|March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer|August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Pageof 27